biography

dr. akers research expertise as a clinical pharmaceutical scientist over the past 25 years bridges the pre-clinical and clinical phases of small molecule drug development in the areas of pre-formulation and formulation development, drug metabolism and drug transporter assessment, and the analysis of pharmacokinetic and pharmacodynamics relationships in cell-based assays, isolated organs, whole animal models, and humans. collectively, he has conducted and participated in investigator initiated and pharmaceutical industry sponsored pre‐clinical and clinical research trials at all levels of drug development with a particular emphasis on pharmacokinetic-pharmacodynamic study design, execution, and analysis.

he remains active as a clinical and translational research scientist and serves as a research mentor for undergraduate students, graduate students, and junior faculty members as they transition into independent research careers. ongoing clinical and translational research projects in collaboration with investigators at academic institutions and within the pharmaceutical industry include pre-clinical in vitro drug metabolism experiments, pharmacokinetic modeling and simulation, and execution of first-in-human studies.

he is the director of the pharmaceutical sciences research center and research training programs at 世界杯2022预选赛录像回放 and co-director of the cross institutional pharm.d.-to-ph.d. pathway program between 世界杯2022预选赛录像回放 and the department of pharmacology at vanderbilt university. as the director of the pharmaceutical sciences research center at 世界杯2022预选赛录像回放 , he oversees the operations of a state-of-art bioanalytical core laboratory that provides hplc, lc-ms, lc-ms/ms analytical instrumentation to develop and validate quantitative drug assays in both the preclinical and clinical phases of drug development.

academic degrees

pharm.d., doctor of pharmacy - university of tennessee (1991)

ph.d. in pharmaceutical sciences - university of kentucky (1998)

academic department

college of pharmacy